Search results
Lantheus Holdings Names Jeffrey Humphrey to Be Medical Chief
Market Watch· 5 days agoBy Ben Glickman Lantheus Holdings named Jeffrey Humphrey as its next chief medical officer, effective May 28. The Bedford, Mass.-based company, which makes...
Biden's latest push to take control of the inflation narrative
Axios· 10 hours agoThe Biden administration released a memo to its allies outlining its actions to combat rising costs...
Boston’s Rapport Therapeutics lays out plans for IPO - Boston Business Journal
The Business Journals· 5 hours agoJust a year after emerging from stealth, a Boston startup working on precision medicines for brain...
Immunotherapy may boost survival after lung cancer surgery
United Press International via Yahoo News· 4 days agoImmunotherapy can boost the survival of early-stage lung cancer patients eligible for surgery when...
Fulgent Announces Second Drug in Development and New Prenatal Genetic Test
Los Angeles Business Journal· 8 hours agoEl Monte-based genetic testing and analysis company Fulgent Genetics Inc., which rode the Covid...
KRAS inhibitors: The next frontier beckons
Pharmaceutical Technology via Yahoo Finance· 5 days agoAlthough KRAS and its links to cancer were discovered decades ago, the characteristics of its protein structure were thought to make it “undruggable”....
Mindy Kaling said she'd like to retire in this Mass. vacation spot
Cape Cod Times via Yahoo News· 4 days agoActress Mindy Kaling, a Cambridge native, said what her dream vacation spot in Massachusetts might...
Bank of America Predicts up to ~200% Surge for These 2 ‘Strong Buy’ Stocks
TipRanks via Yahoo Finance· 1 day agoNew indicators of a cooling economy eased inflation concerns, driving the S&P 500 to record highs...
Perioperative Nivolumab Boosts EFS in Resectable Lung Cancer
MedPage Today· 6 days agoCheckMate 77T trial shows 42% reduction in risk of tumor recurrence, progression, or death
In RA Treatment, Don't Overlook Underlying CV Risks
Medscape· 5 days agoPatients with rheumatoid arthritis (RA) carry a high risk for cardiovascular events, but mounting clinical evidence suggests they're being undertreated...